This parasiticide product was previously approved for killing adult fleas ( Ctenocephalides felis ), treating and preventing ...

Regulators need to know that our most important health care problem is not that people are taking too many prescription drugs ...

The FDA has approved updated drug labeling for Sandoz in the treatment of B-cell chronic lymphocytic leukemia.

Most common exclusion criteria were major depressive disorder, malignant neoplasms, liver disease, uncontrolled HTN ...

The correction was issued following the FDA’s letter citing the potential risk of exposure to toxic compounds when using ...

The FDA updated the fludarabine phosphate injection labeling under Project Renewal, clarifying the dosage for combination ...

Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the ...

Bayer BAYRY announced that the FDA has accepted its supplemental new drug application (sNDA) for Nubeqa (darolutamide). The ...

An anxiety drug is being voluntarily recalled over a mislabeling error that could be “possibly life-threatening," according ...

The Food and Drug Administration has advanced a long awaited proposed rule on front-of-package nutrition labels, signaling a ...

(WJW) – A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for some lots of ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...